Skip to main content

Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.

Publication ,  Journal Article
Benson, AB; Venook, AP; Cederquist, L; Chan, E; Chen, Y-J; Cooper, HS; Deming, D; Engstrom, PF; Enzinger, PC; Fichera, A; Grem, JL; Grothey, A ...
Published in: J Natl Compr Canc Netw
March 2017

This portion of the NCCN Guidelines for Colon Cancer focuses on the use of systemic therapy in metastatic disease. Considerations for treatment selection among 32 different monotherapies and combination regimens in up to 7 lines of therapy have included treatment history, extent of disease, goals of treatment, the efficacy and toxicity profiles of the regimens, KRAS/NRAS mutational status, and patient comorbidities and preferences. Location of the primary tumor, the BRAF mutation status, and tumor microsatellite stability should also be considered in treatment decisions.

Duke Scholars

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

March 2017

Volume

15

Issue

3

Start / End Page

370 / 398

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Time Factors
  • Retreatment
  • Oncology & Carcinogenesis
  • Neoplasm Staging
  • Neoplasm Metastasis
  • Humans
  • Disease Progression
  • Disease Management
  • Combined Modality Therapy
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Benson, A. B., Venook, A. P., Cederquist, L., Chan, E., Chen, Y.-J., Cooper, H. S., … Freedman-Cass, D. (2017). Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 15(3), 370–398. https://doi.org/10.6004/jnccn.2017.0036
Benson, Al B., Alan P. Venook, Lynette Cederquist, Emily Chan, Yi-Jen Chen, Harry S. Cooper, Dustin Deming, et al. “Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw 15, no. 3 (March 2017): 370–98. https://doi.org/10.6004/jnccn.2017.0036.
Benson AB, Venook AP, Cederquist L, Chan E, Chen Y-J, Cooper HS, et al. Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017 Mar;15(3):370–98.
Benson, Al B., et al. “Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw, vol. 15, no. 3, Mar. 2017, pp. 370–98. Pubmed, doi:10.6004/jnccn.2017.0036.
Benson AB, Venook AP, Cederquist L, Chan E, Chen Y-J, Cooper HS, Deming D, Engstrom PF, Enzinger PC, Fichera A, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wu CS, Gregory KM, Freedman-Cass D. Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017 Mar;15(3):370–398.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

March 2017

Volume

15

Issue

3

Start / End Page

370 / 398

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Time Factors
  • Retreatment
  • Oncology & Carcinogenesis
  • Neoplasm Staging
  • Neoplasm Metastasis
  • Humans
  • Disease Progression
  • Disease Management
  • Combined Modality Therapy